1. Home
  2. CNDT vs ENLV Comparison

CNDT vs ENLV Comparison

Compare CNDT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

N/A

Current Price

$1.38

Market Cap

232.4M

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

N/A

Current Price

$1.15

Market Cap

249.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNDT
ENLV
Founded
2016
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.4M
249.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
CNDT
ENLV
Price
$1.38
$1.15
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
1.4M
509.7K
Earning Date
02-11-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,072,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$0.66
52 Week High
$4.90
$2.10

Technical Indicators

Market Signals
Indicator
CNDT
ENLV
Relative Strength Index (RSI) 33.26 65.52
Support Level $1.35 $1.01
Resistance Level $1.54 $1.26
Average True Range (ATR) 0.12 0.09
MACD -0.03 0.01
Stochastic Oscillator 12.01 79.41

Price Performance

Historical Comparison
CNDT
ENLV

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: